Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022.
Kevin James DownesVictoria A StatlerRachel C OrschelnMelissa K CousinoMichael GreenMarian G MichaelsWilliam J MullerTanvi S SharmaLara A Danziger-IsakovMonica I ArduraPublished in: Journal of the Pediatric Infectious Diseases Society (2021)
The COVID-19 pandemic continues to generate challenges for pediatric solid organ transplant (SOT) recipients and their families. As rates of COVID-19 fluctuate, new SARS-CoV-2 variants emerge, and adherence to and implementation of mitigation strategies vary from community to community, questions remain about the best and safest practices to prevent COVID-19 in vulnerable patients. Notably, decisions about returning to school remain difficult. We assembled a team of specialists in pediatric infectious diseases, transplant infectious diseases, public health, transplant psychology, and infection prevention and control to re-address concerns about school re-entry, as well as COVID-19 vaccines, for pediatric SOT recipients in the United States in 2021. Based on available literature and guidance from national organizations, we generated expert statements specific to pediatric SOT recipients focused on school attendance in 2021.
Keyphrases
- sars cov
- infectious diseases
- coronavirus disease
- mental health
- physical activity
- public health
- healthcare
- respiratory syndrome coronavirus
- primary care
- quality improvement
- systematic review
- ejection fraction
- type diabetes
- kidney transplantation
- gene expression
- dna methylation
- genome wide
- young adults
- clinical practice
- patient reported outcomes
- insulin resistance